Background illustration for clinical trials search

Paid Clinical Trials Conway

Discover 480 paid clinical trials in Conway, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Little Rock AR, Rogers AR, Flowood MS, Dallas TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18+

Code: NCT06701903

Phase 2, Recruiting

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

for
Excessive Sleepiness, Shift-work Disorder
Location: Little Rock AR, Chesterfield MO, St Louis MO, Auburn AL,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06568367

Phase 3, Recruiting

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

for
Weight Management
Location: Little Rock AR, Tulsa OK, Alexandria LA, Dallas TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07667803

Phase 3, Recruiting

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

for
Type 2 Diabetes
Location: Little Rock AR, Decatur GA, Gaffney SC, Lake City FL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07606066

Recruiting

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania

for
Bipolar I Disorder, Mania
Location: Little Rock AR, Houston TX, Austin TX, Gaithersburg MD,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07288320

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bentonville AR, St Louis MO,
Sponsor: LB Pharmaceuticals Inc.

Sex: All

Age: 18 - 65

Code: NCT07363577

Phase 3, Recruiting

Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design

for
Fibromyalgia
Location: Little Rock AR, Memphis TN, Springfield MO, Tulsa OK,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07398417

Phase 3, Recruiting

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

for
Type 2 Diabetes
Location: Little Rock AR, Olive Branch MS, Oklahoma City OK,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07754461

Phase 3, Recruiting

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

for
Cognitive Impairment Associated With Schizophrenia (CIAS)
Location: Little Rock AR, St Louis MO, Austin TX, Atlanta GA,
Sponsor: Kynexis B.V.

Sex: All

Age: 18 - 55

Code: NCT07191483

Phase 2, Recruiting

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, North Canton OH, Riverside CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07105098

Phase 3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,
Location: Little Rock AR, Rogers AR, Memphis TN, O'Fallon MO,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07172516

Phase 3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Little Rock AR, Olive Branch MS, Shreveport LA,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase 3, Recruiting

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bryant AR, Flowood MS, St Louis MO,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT07114874

Phase 3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Little Rock AR, Memphis TN, Springfield MO,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Little Rock AR, Springdale AR, Paducah KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase 3, Recruiting

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

for
Tardive Dyskinesia
Location: Little Rock AR, Oklahoma City OK, Kansas City MO,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT03062033

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Little Rock AR, Memphis TN, West Monroe LA, Jackson TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

for
Schizophrenia
Location: Little Rock AR, Bryant AR, DeSoto TX, Houston TX,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18 - 65

Code: NCT06963034

Phase 3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Little Rock AR, Springfield MO, Shreveport LA,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase 3, Recruiting

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

for
Amblyopia
Location: Little Rock AR, Memphis TN, Prairie Village KS,
Sponsor: Jaeb Center for Health Research

Sex: All

Age: 4 - 7

Code: NCT06380517

Phase 3, Recruiting